Skip to main content
Premium Trial:

Request an Annual Quote

PerkinElmer Q4 Revenues Expected to Rise 66 Percent

NEW YORK – PerkinElmer said on Monday that it expects revenue growth of about 66 percent for the fourth quarter of 2020.

PerkinElmer posted total revenues of $805.5 million in Q4 2019.

Organically, revenue growth is anticipated to be around 63 percent for the three months ended Jan. 3, it said, while GAAP earnings per share from continuing operations are expected to be at least $2.88 and adjusted EPS from continuing operations are expected to be at least $3.60, well above the Wall Street consensus forecast of $2.79.

The Waltham, Massachusetts-based firm attributed its performance to better-than-expected demand for its COVID-19, as well as non-COVID-19 products. COVID-19-related products contributed about $535 million to revenues, while non-COVID-19 products declined about 3 percent organically.

The company is scheduled to release its Q4 financial results on Feb. 2.

The Scan

Quality Improvement Study Compares Molecular Tumor Boards, Central Consensus Recommendations

With 50 simulated cancer cases, researchers in JAMA Network Open compared molecular tumor board recommendations with central consensus plans at a dozen centers in Japan.

Lupus Heterogeneity Highlighted With Single-Cell Transcriptomes

Using single-cell RNA sequencing, researchers in Nature Communications tracked down immune and non-immune cell differences between discoid lupus erythematosus and systemic lupus erythematosus.

Rare Disease Clues Gleaned From Mobile Element Insertions in Exome Sequences

With an approach called MELT, researchers in the European Journal of Human Genetics uncovered mobile element insertions in exomes from 3,232 individuals with or without developmental or neurological abnormalities.

Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients

Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.